Medicare Part D Proposed Rule To Lower Prices Targets PBMs, Benefits Manufacturers

Proposal reflects a concern that plans and pharmacy benefit managers are inappropriately benefitting from price concessions (in this case from pharmacies) while beneficiaries are not, a theme the pharma industry has been pushing for some time.

A Surprise Gift From CMS? • Source: Alamy

The Centers for Medicare and Medicaid Services is proposing to lower drug prices for beneficiaries in the Medicare Part D program without tapping manufacturer revenues and in fact, could end up boosting them.

Effective beginning in 2023, CMS would require Part D plans and pharmacy benefit managers to pass through pharmacy price concessions...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access